Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval for a proposed name change to LataMed AI Corp. and a corresponding change to the company's trading symbol. The move is intended to better reflect the company's strategic direction following its transition toward artificial intelligence-enabled healthcare technology, including healthcare analytics and technology-enabled healthcare services infrastructure, with an initial focus on Latin America.
The proposed corporate action was approved by the company's Board of Directors and by written consent of the majority shareholder in accordance with Nevada law. The company emphasized that the proposal does not involve any reverse stock split, forward stock split, recapitalization, change to authorized capital, or other modification to its capital structure. The issued and outstanding share count will remain unchanged, and shareholders' ownership interests will not be affected. No action is required by existing shareholders.
Upon FINRA approval, the company intends to file a Certificate of Amendment with the Nevada Secretary of State to effect the name change. The changes would become effective upon completion of required corporate filings and publication by FINRA on the Daily List. However, no assurance can be given that FINRA will approve the proposed name change, the requested new trading symbol, or the timing of any such approval.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: "There is no change to the Company's capital structure as part of this process. This proposed name change is intended to better align the Company's public identity with its healthcare technology strategy and long-term market focus."
The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
